To access this element change to forms mode OFF
Grant Award View - GA58874
Improving breast cancer outcomes by overcoming resistance to CDK4/6...
GA ID:
GA58874
Agency:
National Health and Medical Research Council (NHMRC)
Approval Date:
1-Aug-2019
Publish Date:
30-Sep-2019
Category:
Medical Research
Grant Term:
1-Jan-2020 to 31-Dec-2024
Value (AUD):
$1,443,588.00
(GST inclusive where applicable)
One-off/Ad hoc:
No
Aggregate Grant Award:
No
PBS Program Name:
NHMRC 19/20 1.1 Health and Medical Research
Grant Program:
Investigator
Grant Activity:
Improving breast cancer outcomes by overcoming resistance to CDK4/6 inhibitors
Purpose:
CDK4/6 inhibitors are a new class of cancer therapy used for the treatment of metastatic breast cancer. Although they are effective, cancers invariably develop resistance to these drugs over time and the reasons for this are unclear. Here, I will study mechanisms of CDK4/6 inhibitor resistance in the lab and will test several therapeutic approaches which have the potential to overcome it. If my results are promising, these new treatments could be readily taken into clinical trials.
GO ID:
GO Title:
Investigator Grants 2019
Internal Reference ID:
GNT1177357
Selection Process:
Targeted or Restricted Competitive
Confidentiality - Contract:
Yes
Confidentiality Reason(s) - Contract:
Privacy Act 1988
Intellectual property
Intellectual property
Confidentiality - Outputs:
Yes
Confidentiality Reason(s) - Outputs:
Intellectual property
Grant Recipient Details
Recipient Name:
University of Melbourne
Recipient ABN:
84 002 705 224
Grant Recipient Location
Suburb:
Parkville
Town/City:
Parkville
Postcode:
3052
State/Territory:
VIC
Country:
AUSTRALIA
Grant Delivery Location
State/Territory:
VIC
Postcode:
Country:
AUSTRALIA